503A compounding pharmacies. Compounded sema/tirz are not FDA-approved.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.
Cancellation and Refund
Full refund anytime before a licensed provider completes the prescription review. Once fulfillment begins, orders are non-refundable. Cancel future months anytime before the next shipment.